A citation-based method for searching scientific literature


List of co-cited articles
800 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML.
K Summers, J Stevens, I Kakkas, M Smith, L L Smith, F Macdougall, J Cavenagh, D Bonnet, B D Young, T A Lister,[...]. Leukemia 2007
76
43

Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party.
Priya Virappane, Rosemary Gale, Robert Hills, Ioannis Kakkas, Karin Summers, Jane Stevens, Christopher Allen, Claire Green, Hilmar Quentmeier, Hans Drexler,[...]. J Clin Oncol 2008
147
30


Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
Peter Paschka, Guido Marcucci, Amy S Ruppert, Susan P Whitman, Krzysztof Mrózek, Kati Maharry, Christian Langer, Claudia D Baldus, Weiqiang Zhao, Bayard L Powell,[...]. J Clin Oncol 2008
185
28

WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia.
K Inoue, H Sugiyama, H Ogawa, M Nakagawa, T Yamagami, H Miwa, K Kita, A Hiraoka, T Masaoka, K Nasu. Blood 1994
486
27

Mutations in the Wilms' tumor gene WT1 in leukemias.
L King-Underwood, J Renshaw, K Pritchard-Jones. Blood 1996
120
27

High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome.
L Bergmann, C Miething, U Maurer, J Brieger, T Karakas, E Weidmann, D Hoelzer. Blood 1997
267
26

Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia.
K Inoue, H Ogawa, Y Sonoda, T Kimura, H Sakabe, Y Oka, S Miyake, H Tamaki, Y Oji, T Yamagami,[...]. Blood 1997
286
25

A tumor suppressor and oncogene: the WT1 story.
L Yang, Y Han, F Suarez Saiz, M D Minden. Leukemia 2007
342
25

Expression of the Wilms' tumor gene (WT1) in human leukemias.
H Miwa, M Beran, G F Saunders. Leukemia 1992
317
22


Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.
K M Call, T Glaser, C Y Ito, A J Buckler, J Pelletier, D A Haber, E A Rose, A Kral, H Yeger, W H Lewis. Cell 1990
20

Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group.
Verena Ingeborg Gaidzik, Richard Friedrich Schlenk, Simone Moschny, Annegret Becker, Lars Bullinger, Andrea Corbacioglu, Jürgen Krauter, Brigitte Schlegelberger, Arnold Ganser, Hartmut Döhner,[...]. Blood 2009
123
20

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
Brunangelo Falini, Cristina Mecucci, Enrico Tiacci, Myriam Alcalay, Roberto Rosati, Laura Pasqualucci, Roberta La Starza, Daniela Diverio, Emanuela Colombo, Antonella Santucci,[...]. N Engl J Med 2005
19

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
Richard F Schlenk, Konstanze Döhner, Jürgen Krauter, Stefan Fröhling, Andrea Corbacioglu, Lars Bullinger, Marianne Habdank, Daniela Späth, Michael Morgan, Axel Benner,[...]. N Engl J Med 2008
19

Mutations of the WT1 gene in childhood nonlymphoid hematological malignancies.
K Miyagawa, Y Hayashi, T Fukuda, K Mitani, H Hirai, K Kamiya. Genes Chromosomes Cancer 1999
31
58

Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
H D Menssen, H J Renkl, U Rodeck, J Maurer, M Notter, S Schwartz, R Reinhardt, E Thiel. Leukemia 1995
225
18


Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.
Christian Thiede, Christine Steudel, Brigitte Mohr, Markus Schaich, Ulrike Schäkel, Uwe Platzbecker, Martin Wermke, Martin Bornhäuser, Markus Ritter, Andreas Neubauer,[...]. Blood 2002
17

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.
T Pabst, B U Mueller, P Zhang, H S Radomska, S Narravula, S Schnittger, G Behre, W Hiddemann, D G Tenen. Nat Genet 2001
669
16

Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients.
D Cilloni, E Gottardi, D De Micheli, A Serra, G Volpe, F Messa, G Rege-Cambrin, A Guerrasio, M Divona, F Lo Coco,[...]. Leukemia 2002
181
16

Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia.
Eva Barragán, José Cervera, Pascual Bolufer, Sandra Ballester, Guillermo Martín, Pascual Fernández, Rosa Collado, María Josè Sayas, Miguel Angel Sanz. Haematologica 2004
93
17

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.
Susanne Schnittger, Claudia Schoch, Wolfgang Kern, Cristina Mecucci, Claudia Tschulik, Massimo F Martelli, Torsten Haferlach, Wolfgang Hiddemann, Brunangelo Falini. Blood 2005
516
16

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.
Konstanze Döhner, Richard F Schlenk, Marianne Habdank, Claudia Scholl, Frank G Rücker, Andrea Corbacioglu, Lars Bullinger, Stefan Fröhling, Hartmut Döhner. Blood 2005
575
16

WT1 proteins: functions in growth and differentiation.
V Scharnhorst, A J van der Eb, A G Jochemsen. Gene 2001
253
15

CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations.
Stefan Fröhling, Richard F Schlenk, Ina Stolze, Jörg Bihlmayr, Axel Benner, Sylvia Kreitmeier, Karen Tobis, Hartmut Döhner, Konstanze Döhner. J Clin Oncol 2004
339
15

A clinical overview of WT1 gene mutations.
M Little, C Wells. Hum Mutat 1997
275
14

High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.
Hélène Lapillonne, Aline Renneville, Anne Auvrignon, Cyril Flamant, Annick Blaise, Christine Perot, Jean-Luc Lai, Paola Ballerini, Françoise Mazingue, Sylvie Fasola,[...]. J Clin Oncol 2006
125
14

The role of the Wilms tumour gene (WT1) in normal and malignant haematopoiesis.
Suzie Ariyaratana, David M Loeb. Expert Rev Mol Med 2007
80
17

Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia.
D Schmid, G Heinze, B Linnerth, K Tisljar, R Kusec, K Geissler, C Sillaber, K Laczika, M Mitterbauer, S Zöchbauer,[...]. Leukemia 1997
89
14

WT-1 is required for early kidney development.
J A Kreidberg, H Sariola, J M Loring, M Maeda, J Pelletier, D Housman, R Jaenisch. Cell 1993
13

The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia.
Hiroyasu Ogawa, Hiroya Tamaki, Kazuhiro Ikegame, Toshihiro Soma, Manabu Kawakami, Akihiro Tsuboi, Eui Ho Kim, Naoki Hosen, Masaki Murakami, Tatsuya Fujioka,[...]. Blood 2003
186
13


Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association.
Aline Renneville, Nicolas Boissel, Virginie Zurawski, Laura Llopis, Valéria Biggio, Olivier Nibourel, Nathalie Philippe, Xavier Thomas, Hervé Dombret, Claude Preudhomme. Cancer 2009
54
24

Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells.
K Inoue, H Tamaki, H Ogawa, Y Oka, T Soma, T Tatekawa, Y Oji, A Tsuboi, E H Kim, M Kawakami,[...]. Blood 1998
144
12

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.
Y Yamamoto, H Kiyoi, Y Nakano, R Suzuki, Y Kodera, S Miyawaki, N Asou, K Kuriyama, F Yagasaki, C Shimazaki,[...]. Blood 2001
878
12

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).
John C Byrd, Krzysztof Mrózek, Richard K Dodge, Andrew J Carroll, Colin G Edwards, Diane C Arthur, Mark J Pettenati, Shivanand R Patil, Kathleen W Rao, Michael S Watson,[...]. Blood 2002
12

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).
Christian Thiede, Sina Koch, Eva Creutzig, Christine Steudel, Thomas Illmer, Markus Schaich, Gerhard Ehninger. Blood 2006
498
12

Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia.
Iris H I M Hollink, Marry M van den Heuvel-Eibrink, Martin Zimmermann, Brian V Balgobind, Susan T C J M Arentsen-Peters, Marielle Alders, Andre Willasch, Gertjan J L Kaspers, Jan Trka, Andre Baruchel,[...]. Blood 2009
84
14




Expression of the tumor suppressor gene WT1 in both human and mouse bone marrow.
G C Fraizer, P Patmasiriwat, X Zhang, G F Saunders. Blood 1995
70
15

Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis.
T Yamagami, H Sugiyama, K Inoue, H Ogawa, T Tatekawa, M Hirata, T Kudoh, T Akiyama, A Murakami, T Maekawa. Blood 1996
216
11

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA).
Claude Preudhomme, Christophe Sagot, Nicolas Boissel, Jean-Michel Cayuela, Isabelle Tigaud, Stéphane de Botton, Xavier Thomas, Emmanuel Raffoux, Charlotte Lamandin, Sylvie Castaigne,[...]. Blood 2002
368
11

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study.
M L Slovak, K J Kopecky, P A Cassileth, D H Harrington, K S Theil, A Mohamed, E Paietta, C L Willman, D R Head, J M Rowe,[...]. Blood 2000
11

AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1.
Sumiyuki Nishida, Naoki Hosen, Toshiaki Shirakata, Keisuke Kanato, Masashi Yanagihara, Shin-ichi Nakatsuka, Yoshihiko Hoshida, Tsutomu Nakazawa, Yukie Harada, Naoya Tatsumi,[...]. Blood 2006
86
12

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.
Stefan Fröhling, Richard F Schlenk, Jochen Breitruck, Axel Benner, Sylvia Kreitmeier, Karen Tobis, Hartmut Döhner, Konstanze Döhner. Blood 2002
645
11

Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia.
M Weisser, W Kern, S Rauhut, C Schoch, W Hiddemann, T Haferlach, S Schnittger. Leukemia 2005
129
11

Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.
Daniela Cilloni, Aline Renneville, Fabienne Hermitte, Robert K Hills, Sarah Daly, Jelena V Jovanovic, Enrico Gottardi, Milena Fava, Susanne Schnittger, Tamara Weiss,[...]. J Clin Oncol 2009
310
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.